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Objective. This report describes a severe case of hyperglycemic hyperosmolar syndrome complicated by rhabdomyolysis, acute
kidney injury, hyperthermia, and hypovolemic shock, with management centred upon fluid administration. Design. Case report.
Setting. Pediatric intensive care unit in university teaching hospital. Patients. 12 years old adolescent female presenting with
hyperglycemic hyperosmolar syndrome with a new diagnosis of type 2 diabetes mellitus. Intervention. Aggressive fluid resuscitation
and insulin. Main results. The patient had a good outcome, discharged home on hospital day 6. Conclusions. Hyperglycemic
hyperosmolar syndrome is associated with a number of complications. Management strategies are undefined, given the rarity
of its presentation, and further studies are warranted.
1. Introduction
Recent trends indicate a rising percentage of type two dia-
betes in the under eighteen population, with a prevalence of
0.22 cases per 1000 youth [1] amongst the American popula-
tion. Hyperglycemic hyperosmolar syndrome (HHS), a rare
pediatric complication of diabetes mellitus (DM), is charac-
terized by the triad of hyperglycemia (typically> 600 mg/dL),
hyperosmolality (serum osmolality >330 mOsm/L), and a
mild metabolic acidosis (pH > 7.2). It portends a very
poor prognosis, with mortality rates of between 10–50%
in adults [2]. In children, similar mortality rates have been
observed [3], although most of the literature is limited
to case series and reports. In adults, documented major
complications include thrombosis, rhabdomyolysis, renal
failure, and irreversible cardiac arrhythmias [4]. A formal
distinction between HHS and diabetic ketoacidosis (DKA)
exists, with DKA typically presenting with lower levels
of hyperglycemia, ketosis, and more significant metabolic
acidosis, although these two illnesses are more likely on the
spectrum of decompensations related to diabetes [2]. HHS
is classically associated with type 2 DM, although it has also
been increasingly reported in type 1 DM [5, 6] as well. DKA
has a much better prognosis, with pediatric mortality rates
below 1% [7], and cerebral edema being the major cause of
death.
We present a case of an adolescent girl with newly
diagnosed HHS and review some of the current literature on
the presentation and management of pediatric HHS.
2. Case Presentation
The patient was a previously healthy 12 year-old African
American female who presented to the emergency room
with a chief complaint of altered mental status. She had
been having upper-respiratory symptoms for the preceding
4–5 days, with diarrhea and vomiting for three days. She
was thirsty, supplementing her diet with milkshakes and
smoothies. The night prior to presentation, she awoke
somewhat disoriented, which the parents assumed was a
bad dream. On the day of presentation, the patient became
progressively weak and sleepy, before presenting to the
emergency room with lethargy.
Review of systems was notable for mild polydipsia, some
nocturia over the past few nights, no fevers, and no myalgia.
2 International Journal of Pediatric Endocrinology
There is a paternal family history of type 1 DM, and no
history of gestational diabetes. There is a significant family
history for obesity.
Upon presentation, the patient had a Glasgow Coma
Scale of 7. Vital signs were as follows: heart rate 159 bpm,
respiratory rate of 20 breaths per minute, and temperature of
104.4◦F (40.2◦C). Blood pressure was 79/37 mm Hg. Weight
was 65 kg, and BMI was 26 kg/m2 (80th percentile for age).
An initial rapid glucose test read >750 mg/dL. Pupils were
equal and responsive to light. Mucus membranes were dry.
The neck was supple with no jugular venous distension
and notable for acanthosis nigricans. There were decreased
breath sounds on the right base, with some nasal flaring,
but no significant respiratory distress. Cardiac examination
was consistent with sinus tachycardia and no murmurs. Pedal
pulses were minimally palpable. Abdomen was obese, soft
and non-distended, with no hepatosplenomegaly. Striae were
present on the flanks.
Initial laboratory evaluation revealed: arterial blood gas
pH 7.12; PCO2 50 mmHg; HCO3 15 mM; PaO2 99 mmHg.
Complete blood count had a white blood count of 14.6/µL, a
hematocrit of 37% and a platelet count of 507,000/µL. Elec-
trolytes were the following: sodium (Na): 137 mM (corrected
Na using the formula: Corrected Na=Measured Na + 1.6
(glucose (mg/dL) −100) was 185 mM); potassium: 5.2 mM;
chloride: 102 mM, phosphorus: 4.5 mg/dL. Serum glucose:
2636 mg/dL, Osmolality: 466 mOsm/L; BUN: 77 mg/dL; Cre-
atinine: 4.08 mg/dL; troponin I 0.268 ng/ml (N < 0.1); lactic
acid: 7.6 mM, amylase 112 U/L; hemoglobin A1C 11.5%;
liver enzymes and coagulation profile were normal; islet cell
antibody: negative; glutamic acid decarboxylase antibody:
negative; urinalysis with 3+ glucose and trace ketones.
A chest X-ray was unremarkable. Because of the high
fever and the altered mental status, a head CT and a lumbar
puncture were performed. The CT was not consistent with
cerebral edema. Lumbar puncture had an opening pressure
of 30 cm of H2O and a closing pressure of 27 cm of H2O. CSF
studies revealed: 0 RBC, 1 WBC, protein 51 mg/dL, glucose
869 mg/dL, and a negative gram stain.
The patient received 3 L of normal saline intravenously
over a span of three hours in the emergency room, with some
improvement in mental status and blood pressure. She was
started on a regular insulin drip at 0.1 U/kg/hour and was
transferred to the pediatric intensive care unit.
In the PICU, the patient persisted in hypovolemic
shock and required aggressive fluid resuscitation with
approximately 100 mL/kg of isotonic fluid boluses over
the first 12 hours, as well as dopamine with maximal
dosing of 5 mcg/kg/min for hemodynamic support. She
was started on intravenous hydration with 154 mEq/L of
sodium acetate with added potassium chloride and potas-
sium phosphate. Vancomycin and ceftriaxone were initiated.
She was placed on BiPAP for ventilatory support due to
persistent desaturations. She was started on enoxaparin for
DVT prophylaxis. Glucose decreased at a rate of approxi-
mately 130 mg/dL/hour, with an increasing serum sodium
(Figure 1). Mental status continued to improve and 12
hours post-presentation, she responded to commands and










































Figure 1: Serum glucose and sodium during hospitalization.
hemodynamic and ventilatory support, but continued to
require fluid resuscitation with only slow improvement in
serum lactic acid levels, receiving a total of 20 L of isotonic
fluid in the first 36 hours of admission. As mental status
recovered, she transitioned oﬀ the insulin infusion to a
subcutaneous regimen. All laboratory values and vital signs
continued to improve, including serum troponin, BUN, and
creatinine and urine output continued to be brisk. She
reported some myalgia, and a CK was 4051 IU/L at 36 hours
post-presentation. She was transitioned to a full diet within
48 hours of presentation. Antibiotics were discontinued after
blood, urine, and CSF cultures were negative at 48 hours. She
maintained an intact neurological examination throughout
her hospitalization. She was transferred to the regular floor
after a 60 hours PICU admission, and was discharged home
on a glargine-containing insulin regimen after a total six-day
hospital course.
3. Discussion
This patient presented with HHS as a complication of
newly diagnosed type 2 diabetes mellitus. The diagnosis
of type 2 DM was made based on the lack of pancreatic
auto-antibodies, historical and physical characteristics, and
a positive family history for type 2 DM. Her presentation
is very similar to previously reported cases of extreme
hyperglycemia in pediatric HHS [8, 9], although her initial
serum glucose was one of the highest reported in the
pediatric population. The absence of earlier symptoms is
emblematic of the classical presentation of HHS, where
the absence of ketosis and acidosis delays the subjective
illness [10], in contrast with the rapid presentation of its
counterpart, DKA [11]. Her initial presentation was also
notable for a metabolic acidosis, likely explained by an
elevated lactic acid level secondary to profound dehydra-
tion and decreased end-organ perfusion. Her significant
hyperthermia at presentation is a published complication
of HHS [9], whose etiology is unknown, but potentially
related to rhabdomyolysis. Contrary to previous reports
[12], her temperature developed prior to administration of
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insulin, negating the insulin preservative m-cresol as the
etiology of her hyperthermia. Undiagnosed inborn errors
of metabolism, severe physiologic stress, or undiagnosed
infection are unlikely reasons for her initial hyperthermia.
Hyperglycemic hyperosmolar state occurs when pro-
gressive insulin resistance worsens in the setting of some
physiologic stress, driving up serum glucose while still
retaining an eﬀect on the suppression of lipolysis. Given
the hormonal sensitivity of the adipocyte, ketosis is sup-
pressed with the residual activity of insulin. An upregulation
in glucagon release secondary to the decreased activity
of insulin contributes to hepatic gluconeogenesis, further
augmenting the hyperglycemic state [13, 14]. The worsening
hyperglycemia hastens osmotic diuresis, leading to hyperna-
tremic dehydration, as excess water is lost with respect to salt.
Once renal glucose clearance capacity is overwhelmed and
GFR becomes compromised, a hyperosmolar state develops,
leading to the clinical signs and symptoms, including the
altered mental status and profound dehydration.
Given the severe dehydration, often estimated to be up to
20% of body volume, and residual insulin activity in HHS,
management strategies centre upon fluid administration.
Evidence based guidelines in children are lacking, so data are
extrapolated from adult guidelines, children with DKA, and
the few case series of pediatric HHS. What makes this case
notable was the degree of aggressive fluid resuscitation, with
the patient receiving nearly 20 L of intravenous fluids within
the first 36 hours of hospitalization, guided by hypotension
and lactic acidemia. Guidelines for adults recommend
rapid correction of serum osmolality towards a goal of
<320 mOsm/L [4]. In children, some caution is theoretically
warranted, and the fluid administration rate should be
tempered by this risk, with a goal reduction in serum glucose
of 100–150 mg/dL/hour. In some pediatric reports, however,
poor outcomes have been associated with minimizing fluid
repletion [15], arguing that HHS in children is similar to
HHS in adults, where aggressive fluid resuscitation is the
rule [2, 4]. A previous case of extreme hyperosmolality has
been reported with no significant rise in measured intracra-
nial pressure with a relatively rapid correction of serum
osmolality [16]. Isotonic solution should be considered to
temper the risk of excessive changes in osmolality until
definitive data are obtained, and any hypovolemic shock
should be corrected aggressively. This is in strict contrast to
management guidelines for pediatric DKA, where the degree
of dehydration is much less, and fluid repletion should be
more carefully administered, given the documented risk of
cerebral edema [17–19].
Pediatric HHS patients are classically quite sensitive
to exogenous insulin, so standardized infusion rates of
0.1 U/kg/hour are recommended. Dextrose is added to
intravenous fluids appropriately to avoid overly precipitous
drops in glucose levels. Upon adequate control of serum
glucose, insulin administration should be switched to an
appropriate subcutaneous regimen. Potassium, phosphate,
and calcium need to be monitored closely, given the risks of
abnormalities through both the pathogenesis and treatment
of HHS. Muscle enzymes should be empirically checked in
every patient with HHS, given the risk of rhabdomyolysis and
its eﬀects on management, considering data on alkalinization
and outcomes in DKA [19]. Also, venous sinus thrombosis
is a potential complication of severe hypernatremia and
hyperosmolality [20], hence the requirement for hydration
and careful control of serum sodium as well as for frequent
neurological examinations. The risk of other venous throm-
botic phenomena, such as pulmonary emboli or deep vein
thrombosis [21], are significant, and these should be closely
monitored.
We report an extreme case of pediatric HHS with a good
outcome. Our patient had many of the known complications
of HHS, including hypovolemic shock, rhabdomyolysis,
acute kidney injury, and hyperthermia, as well as the one of
the highest published serum glucose levels in the pediatric
literature. She responded well to very aggressive fluid resus-
citation and gentle insulin administration. Prospective trials
in this burgeoning population need to be performed so as
to better codify management strategies, especially pertaining
to the intensity of fluid repletion. Although an uncommon
presentation in the pediatric population, clinicians should
be aware of the manifestations of HHS and the diﬀerences
in management from its counterpart, DKA.
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